These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 33402167

  • 1. Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson's disease model.
    Zhang D, Li S, Hou L, Jing L, Ruan Z, Peng B, Zhang X, Hong JS, Zhao J, Wang Q.
    J Neuroinflammation; 2021 Jan 05; 18(1):4. PubMed ID: 33402167
    [Abstract] [Full Text] [Related]

  • 2. Microglial Activation Mediates Noradrenergic Locus Coeruleus Neurodegeneration via Complement Receptor 3 in a Rotenone-Induced Parkinson's Disease Mouse Model.
    Jing L, Hou L, Zhang D, Li S, Ruan Z, Zhang X, Hong JS, Wang Q.
    J Inflamm Res; 2021 Jan 05; 14():1341-1356. PubMed ID: 33859489
    [Abstract] [Full Text] [Related]

  • 3. Microglial gp91phox-mediated neuroinflammation and ferroptosis contributes to learning and memory deficits in rotenone-treated mice.
    Tian L, Tang P, Liu J, Liu Y, Hou L, Zhao J, Wang Q.
    Free Radic Biol Med; 2024 Aug 01; 220():56-66. PubMed ID: 38697489
    [Abstract] [Full Text] [Related]

  • 4. Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease.
    Ding W, Lin H, Hong X, Ji D, Wu F.
    Toxicology; 2020 Apr 30; 436():152437. PubMed ID: 32169474
    [Abstract] [Full Text] [Related]

  • 5. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson's Disease Mouse Model.
    Ruan Z, Zhang D, Huang R, Sun W, Hou L, Zhao J, Wang Q.
    Int J Mol Sci; 2022 Mar 03; 23(5):. PubMed ID: 35269933
    [Abstract] [Full Text] [Related]

  • 6. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.
    Hou L, Qu X, Qiu X, Huang R, Zhao X, Wang Q.
    J Neuroinflammation; 2020 May 06; 17(1):148. PubMed ID: 32375810
    [Abstract] [Full Text] [Related]

  • 7. Rotenone impairs learning and memory in mice through microglia-mediated blood brain barrier disruption and neuronal apoptosis.
    Guo Z, Ruan Z, Zhang D, Liu X, Hou L, Wang Q.
    Chemosphere; 2022 Mar 06; 291(Pt 2):132982. PubMed ID: 34822863
    [Abstract] [Full Text] [Related]

  • 8. Complement receptor 3-mediated neurotoxic glial activation contributes to rotenone-induced cognitive decline in mice.
    Wang Q, Ruan Z, Jing L, Guo Z, Zhang X, Liu J, Tian L, Sun W, Song S, Hong JS, Shih YI, Hou L, Wang Q.
    Ecotoxicol Environ Saf; 2023 Nov 01; 266():115550. PubMed ID: 37832486
    [Abstract] [Full Text] [Related]

  • 9. Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase-NLRP3 inflammasome axis-dependent microglial activation.
    Hou L, Liu J, Sun F, Huang R, Chang R, Ruan Z, Wang Y, Zhao J, Wang Q.
    J Neuroinflammation; 2023 Feb 18; 20(1):42. PubMed ID: 36804009
    [Abstract] [Full Text] [Related]

  • 10. Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease.
    Li Q, Shen C, Liu Z, Ma Y, Wang J, Dong H, Zhang X, Wang Z, Yu M, Ci L, Sun R, Shen R, Fei J, Huang F.
    Cell Prolif; 2021 Aug 18; 54(8):e13094. PubMed ID: 34312932
    [Abstract] [Full Text] [Related]

  • 11. Taurine improves neuron injuries and cognitive impairment in a mouse Parkinson's disease model through inhibition of microglial activation.
    Wang K, Shi Y, Liu W, Liu S, Sun MZ.
    Neurotoxicology; 2021 Mar 18; 83():129-136. PubMed ID: 33450328
    [Abstract] [Full Text] [Related]

  • 12. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R, Singh N, Lawana V, Ghosh A, Harischandra DS, Jin H, Hogan C, Sarkar S, Rokad D, Panicker N, Anantharam V, Kanthasamy AG, Kanthasamy A.
    Neurobiol Dis; 2016 Sep 18; 93():96-114. PubMed ID: 27151770
    [Abstract] [Full Text] [Related]

  • 13. Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
    De Miranda BR, Rocha EM, Bai Q, El Ayadi A, Hinkle D, Burton EA, Timothy Greenamyre J.
    Neurobiol Dis; 2018 Jul 18; 115():101-114. PubMed ID: 29649621
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition.
    Stoll AC, Kemp CJ, Patterson JR, Kubik M, Kuhn N, Benskey M, Duffy MF, Luk KC, Sortwell CE.
    J Neuroinflammation; 2024 Apr 25; 21(1):108. PubMed ID: 38664840
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model.
    Hou L, Sun F, Huang R, Sun W, Zhang D, Wang Q.
    Redox Biol; 2019 Apr 25; 22():101134. PubMed ID: 30798073
    [Abstract] [Full Text] [Related]

  • 18. Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects.
    Mansour RM, Ahmed MAE, El-Sahar AE, El Sayed NS.
    Toxicol Appl Pharmacol; 2018 Nov 01; 358():76-85. PubMed ID: 30222980
    [Abstract] [Full Text] [Related]

  • 19. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ, Ritzel RM, Barrett JP, Doran SJ, Jiao Y, Leach JB, Szeto GL, Wu J, Stoica BA, Faden AI, Loane DJ.
    J Neurosci; 2020 Apr 01; 40(14):2960-2974. PubMed ID: 32094203
    [Abstract] [Full Text] [Related]

  • 20. Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice.
    Rocha SM, Bantle CM, Aboellail T, Chatterjee D, Smeyne RJ, Tjalkens RB.
    Neurobiol Dis; 2022 Jun 01; 167():105685. PubMed ID: 35257879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.